When should an FTO analysis be performed?

An FTO analysis should ideally be initiated early in the research and development phase to guide design choices and mitigate risks, and then periodically updated as the product evolves and prior art landscapes change.

What are the consequences of not having FTO?

Without established FTO, a company faces potential lawsuits for patent infringement, which can result in costly legal fees, injunctions halting product sales, mandatory royalty payments, or significant damages awards.

Can FTO impact regulatory submissions?

While FTO is not a direct part of regulatory submissions like 510(k) or PMA, unresolved infringement issues can disrupt a company's ability to reliably supply a product to market, which indirectly affects a manufacturer's compliance with quality system regulations and post-market obligations.

All terms

CommercializationHospital Buyer & ReimbursementFTO

Freedom to Operate

Analysis of whether a product can be sold without infringing third-party IP.

Reviewed by Christian Espinosa, Founder, Blue Goat CyberLast reviewed May 5, 2026

Definition

An FTO analysis identifies in-force third-party patent claims that could be infringed by a planned product, and assesses design-around or licensing options. Distinct from patentability - a company can have its own patent and still infringe another.

What the regulation says

While not a direct regulatory requirement, maintaining freedom to operate is a de facto expectation for medical device manufacturers, as intellectual property disputes can disrupt supply chains and product availability, which falls under regulatory oversight regarding product quality and safety. Regulators like the FDA expect manufacturers to ensure consistent product supply and quality, which can be jeopardized by unresolved FTO issues. Though not explicitly stated in regulations like 21 CFR 820, the ability to legally market and distribute a device without infringement claims supports compliance with broader quality system requirements.

What this means in practice

Investor and acquirer DD requires clean FTO opinions. Late-stage FTO surprises can derail financings and M&A.

Examples

A startup developing a novel surgical robot conducts an FTO analysis to ensure its mechanical design and software algorithms do not infringe existing patents held by larger medical device companies.
Before launching a new diagnostic assay, a laboratory performs an FTO search to confirm that its reagents and testing methodology do not violate any in-force third-party patent claims.
A manufacturer planning to introduce a next-generation implantable device reviews the FTO landscape to identify potential infringement risks related to materials science or manufacturing processes.

Common pitfalls

•Failing to conduct FTO analysis early in the product development lifecycle can lead to significant redesigns, delays, or even project cancellation.
•Assuming that obtaining your own patent guarantees freedom to operate is a common and dangerous misconception, as separate patents may exist that cover aspects of your device.
•Neglecting to update FTO analyses throughout the product lifecycle as new patents are granted or product designs evolve can expose a company to infringement risks.
•Relying solely on in-house legal opinions without seeking external expert review for complex FTO assessments can lead to overlooked risks.
•Ignoring FTO for software components or ancillary devices that integrate with the main MedTech product can create unexpected legal vulnerabilities.

Frequently asked questions

Patentability refers to whether an invention meets the legal requirements to be granted a patent, such as novelty and non-obviousness. Freedom to Operate, conversely, assesses whether a product can be commercially manufactured, used, or sold without infringing on valid intellectual property rights of others.

Grouped by theme

Editor's picks

· Hand-selected related concepts

Investment & Finance

Due Diligence

Investigation of a company before an investment, financing, or acquisition.

Founder & Investor Primer

· From this learning path

Regulatory

Breakthrough Device Designation(BDD)

FDA program providing expedited review for devices that treat life-threatening or irreversibly debilitating conditions.

Adjacent lesson

Investment & Finance

Series A / B / C Financing Rounds

Sequential priced equity rounds in venture-backed companies, typically progressing from product-market validation (A) to scale (B) to growth (C+).

Adjacent lesson

Commercialization

TAM / SAM / SOM

Market sizing framework: total, serviceable available, and serviceable obtainable.

Regulatory

510(k) Premarket Notification(510(k))

FDA submission demonstrating a device is substantially equivalent to a legally marketed predicate.

Primary references

3 sources

Link health: 3 verified· last checked 2026-06-20

USPTO·1AHRMM·1AdvaMed·1

Inline markers like [1] jump to the matching reference above.

On this term

Category: Commercialization
Acronym: FTO
Sources: 3
Updated: 5/5/2026

Compare with another term

Learn in 60 seconds

Analysis of whether a product can be sold without infringing third-party IP.

·Investor and acquirer DD requires clean FTO opinions.
·Late-stage FTO surprises can derail financings and M&A.
·Distinct from patentability - a company can have its own patent and still infringe another.

Remember this

Watch out: Failing to conduct FTO analysis early in the product development lifecycle can lead to significant redesigns, delays, or even project cancellation.

Related terms

Due Diligence

You may also need

Auto-suggested from Commercialization and shared keywords.

All Commercialization terms